Agonist-Directed Desensitization of the β2-Adrenergic Receptor

被引:40
作者
Goral, Vasiliy [1 ]
Jin, Yan [1 ]
Sun, Haiyan [1 ]
Ferrie, Ann M. [1 ]
Wu, Qi [1 ]
Fang, Ye [1 ]
机构
[1] Corning Inc, Biochem Technol, Div Sci & Technol, Corning, NY 14831 USA
来源
PLOS ONE | 2011年 / 6卷 / 04期
基金
美国国家卫生研究院;
关键词
DYNAMIC MASS REDISTRIBUTION; GUIDE GRATING BIOSENSOR; OPTICAL BIOSENSOR; ENDOTHELIAL-CELLS; SHEAR-STRESS; ACTIVATION; MECHANISMS; SELECTIVITY;
D O I
10.1371/journal.pone.0019282
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The beta(2)-adrenergic receptor (beta(2)AR) agonists with reduced tachyphylaxis may offer new therapeutic agents with improved tolerance profile. However, receptor desensitization assays are often inferred at the single signaling molecule level, thus ligand-directed desensitization is poorly understood. Here we report a label-free biosensor whole cell assay with microfluidics to determine ligand-directed desensitization of the beta(2)AR. Together with mechanistic deconvolution using small molecule inhibitors, the receptor desensitization and resensitization patterns under the short-term agonist exposure manifested the long-acting agonism of salmeterol, and differentiated the mechanisms of agonist-directed desensitization between a full agonist epinephrine and a partial agonist pindolol. This study reveals the cellular mechanisms of agonist-selective beta(2)AR desensitization at the whole cell level.
引用
收藏
页数:8
相关论文
共 37 条
[1]   Sensing G protein-coupled receptor activation [J].
Ambrosio, Manuela ;
Zuern, Alexander ;
Lohse, Martin J. .
NEUROPHARMACOLOGY, 2011, 60 (01) :45-51
[2]  
Fang Ye, 2011, Drug Discov Today Technol, V7, pe5, DOI 10.1016/j.ddtec.2010.05.001
[3]  
[Anonymous], 1998, TOP CHEM ENGN NY
[4]   β-Arrestin-mediated activation of MAPK by inverse agonists reveals distinct active conformations for G protein-coupled receptors [J].
Azzi, M ;
Charest, PG ;
Angers, S ;
Rousseau, G ;
Kohout, T ;
Bouvier, M ;
Piñeyro, G .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (20) :11406-11411
[5]   The selectivity of β-adrenoceptor agonists at human β1-, β2- and β3-adrenoceptors [J].
Baker, Jillian G. .
BRITISH JOURNAL OF PHARMACOLOGY, 2010, 160 (05) :1048-1061
[6]   OPERATIONAL MODELS OF PHARMACOLOGICAL AGONISM [J].
BLACK, JW ;
LEFF, P .
PROCEEDINGS OF THE ROYAL SOCIETY SERIES B-BIOLOGICAL SCIENCES, 1983, 220 (1219) :141-162
[7]   Agonist efficacy and receptor desensitization: from partial truths to a fuller picture [J].
Charlton, Steven J. .
BRITISH JOURNAL OF PHARMACOLOGY, 2009, 158 (01) :165-168
[8]   Mechanotransduction and endothelial cell homeostasis: the wisdom of the cell [J].
Chien, Shu .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2007, 292 (03) :H1209-H1224
[9]   The rush to adrenaline:: drugs in sport acting on the β-adrenergic system [J].
Davis, E. ;
Loiacono, R. ;
Summers, R. J. .
BRITISH JOURNAL OF PHARMACOLOGY, 2008, 154 (03) :584-597
[10]   THE HUMAN CARCINOMA CELL-LINE A431 POSSESSES LARGE NUMBERS OF FUNCTIONAL BETA-ADRENERGIC RECEPTORS [J].
DELAVIERKLUTCHKO, C ;
HOEBEKE, J ;
STROSBERG, AD .
FEBS LETTERS, 1984, 169 (02) :151-155